Investigative Ophthalmology & Visual Science Cover Image for Volume 65, Issue 7
June 2024
Volume 65, Issue 7
Open Access
ARVO Annual Meeting Abstract  |   June 2024
Deep Learning Prediction of Glaucoma Progression using Multimodal Transformers and Longitudinal Clinical Data
Author Affiliations & Notes
  • Justin Huynh
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, California, United States
  • Ruben Cesar Gonzalez
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, California, United States
  • Evan Walker
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, California, United States
  • Benton Gabriel Chuter
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, California, United States
  • Alireza Kamalipour
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, California, United States
  • Christopher Bowd
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, California, United States
  • Akram Belghith
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, California, United States
  • Michael Henry Goldbaum
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, California, United States
  • Massimo Antonio Fazio
    Department of Ophthalmology and Vision Sciences, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, United States
  • Christopher A Girkin
    Department of Ophthalmology and Vision Sciences, The University of Alabama at Birmingham Heersink School of Medicine, Birmingham, Alabama, United States
  • Carlos Gustavo De Moraes
    Bernard and Shirlee Brown Glaucoma Research Laboratory, Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York, New York, United States
  • Jeffrey M Liebmann
    Bernard and Shirlee Brown Glaucoma Research Laboratory, Department of Ophthalmology, Edward S. Harkness Eye Institute, Columbia University Irving Medical Center, New York, New York, United States
  • Robert Weinreb
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, California, United States
  • Sally Liu Baxter
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, California, United States
    Department of Biomedical Informatics, University of California San Diego Health System, San Diego, California, United States
  • Linda M Zangwill
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, California, United States
  • Mark Christopher
    Hamilton Glaucoma Center, Shiley Eye Institute, Viterbi Family Department of Ophthalmology, University of California San Diego, La Jolla, California, United States
  • Footnotes
    Commercial Relationships   Justin Huynh None; Ruben Gonzalez None; Evan Walker None; Benton Chuter None; Alireza Kamalipour None; Christopher Bowd None; Akram Belghith None; Michael Goldbaum None; Massimo Fazio National Eye Institute, EyeSight Foundation of Alabama, Research to Prevent Blindness, Heidelberg Engineering, GmbH, Topcon and Wolfram Research, Code F (Financial Support); Christopher Girkin National Eye Institute, Heidelberg Engineering and Topcon, EyeSight Foundation of Alabama, Research to Prevent Blindness, Heidelberg Engineering, GmbH, Code F (Financial Support); Carlos Moraes Novartis, Galimedix, Belite, Reichert, Carl Zeiss, Perfuse Therapeutics, Code C (Consultant/Contractor), Ora Clinical, Code E (Employment), Heidelberg, Topcon, Code R (Recipient); Jeffrey Liebmann Allergan, Genentech, Thea, Bausch & Lomb, Code C (Consultant/Contractor), Novartis, Research to Prevent Blindness, Code F (Financial Support); Robert Weinreb Abbvie, Aerie Pharmaceuticals, Alcon, Allergan, Equinox, Iantrek, Implandata, Nicox, Santen, Topcon Medical, Code C (Consultant/Contractor), Topcon Medical, Heidelberg Engineering, Carl Zeiss Meditec, Optovue, Centervue, National Eye Institute, National Institute of Minority Health and Disparities, Research to Prevent Blindness , Code F (Financial Support), Toromedes, Carl Zeiss Meditec, Code P (Patent); Sally Baxter voxelcloud.io, Code C (Consultant/Contractor), Optomed, Topcon, Code F (Financial Support), iVista Medical Education, Code R (Recipient); Linda Zangwill Abbvie Inc., Topcon, Code C (Consultant/Contractor), National Eye Institute, Carl Zeiss Meditec Inc., Heidelberg Engineering GmbH, Optovue Inc., Topcon Medical Systems Inc., Code F (Financial Support), Carl Zeiss Meditec, AISight Health, Code P (Patent); Mark Christopher AISight Health, Code P (Patent)
  • Footnotes
    Support  This work is supported by National Institutes of Health/National Eye Institute Grants (R01EY034148, R01EY029058, R01EY11008, R01EY19869, R01EY027510, R01EY026574, EY018926, P30EY022589, K99EY030942, R01EY034146, T35EY033704, DP5OD029610); and an unrestricted grant from Research to Prevent Blindness (New York, NY). The sponsor or funding organization had no role in the design or conduct of this research.
Investigative Ophthalmology & Visual Science June 2024, Vol.65, 1623. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Justin Huynh, Ruben Cesar Gonzalez, Evan Walker, Benton Gabriel Chuter, Alireza Kamalipour, Christopher Bowd, Akram Belghith, Michael Henry Goldbaum, Massimo Antonio Fazio, Christopher A Girkin, Carlos Gustavo De Moraes, Jeffrey M Liebmann, Robert Weinreb, Sally Liu Baxter, Linda M Zangwill, Mark Christopher; Deep Learning Prediction of Glaucoma Progression using Multimodal Transformers and Longitudinal Clinical Data. Invest. Ophthalmol. Vis. Sci. 2024;65(7):1623.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : There is a need for objective, reliable, approaches that can identify glaucoma progressors and facilitate therapy. One limitation of most existing deep learning glaucoma progression models is that they rely solely on single modalities, such as visual field tests or retinal imaging. Another limitation is that most models are not longitudinal, only relying on data taken from a single exam. Single modality, single timepoint approaches may not provide a comprehensive understanding of disease progression, and pose a great obstacle towards building models capable of predicting glaucoma progression. To overcome these limitations we propose a multimodal deep learning model to identify functional visual field based glaucoma progression from baseline 24-2 visual field and patient demographics, clinical measurements, Fundus photographs, OCT, and RNFL thickness captured over multiple follow-up visits.

Methods : Based on at least three 24-2 VF tests, 120 glaucoma patients (138 eyes) were classified as fast progressors (1.0 dB/year or worse mean deviation loss) and 310 glaucoma patients (380 eyes) were classified as stable (less than 1.0 dB/year of loss). Several multimodal transformer models were trained on various data modalities. In addition to baseline OCT scans, RNFL thickness maps, baseline VF, baseline fundus photographs, baseline eye measurements (IOP, SE, AL, CCT), patient demographics (age, sex, race), systemic conditions, and medication history were incorporated into model training. Longitudinal OCT and fundus imaging from follow-up visits were also incorporated.

Results : Models using baseline data achieved an AUC of 0.74 in identifying fast progressors. Adding imaging from one or two follow-up visits increased AUC to 0.83 and 0.86, respectively. Attention vectors reveal relatively equal attention on all data modalities provided as input to the model. Attention vectors on OCT scans reveal model attention focused on the RNFL and choroid. Attention vectors on fundus reveal model attention focused on the optic nerve head. False positive and false negative examples reveal greater attention focused outside the ONH of fundus images.

Conclusions :
Multimodal transformer models identified fast progressors with strong accuracy and could help clinicians identify patients before unmanageable vision loss occurs.

This abstract was presented at the 2024 ARVO Annual Meeting, held in Seattle, WA, May 5-9, 2024.

 

Model performance with only baseline data vs with follow-up data.

Model performance with only baseline data vs with follow-up data.

 

Model attention maps.

Model attention maps.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×